[go: up one dir, main page]

FR3099701B1 - New cosmetic use of a combination of oenotheine-B and quercetin-3-O-glucuronide - Google Patents

New cosmetic use of a combination of oenotheine-B and quercetin-3-O-glucuronide Download PDF

Info

Publication number
FR3099701B1
FR3099701B1 FR1909080A FR1909080A FR3099701B1 FR 3099701 B1 FR3099701 B1 FR 3099701B1 FR 1909080 A FR1909080 A FR 1909080A FR 1909080 A FR1909080 A FR 1909080A FR 3099701 B1 FR3099701 B1 FR 3099701B1
Authority
FR
France
Prior art keywords
combination
glucuronide
quercetin
oenotheine
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1909080A
Other languages
French (fr)
Other versions
FR3099701A1 (en
Inventor
Louis Danoux
Florence Henry
Sabine Pain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Beauty Care Solutions France SAS
Original Assignee
BASF Beauty Care Solutions France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF Beauty Care Solutions France SAS filed Critical BASF Beauty Care Solutions France SAS
Priority to FR1909080A priority Critical patent/FR3099701B1/en
Publication of FR3099701A1 publication Critical patent/FR3099701A1/en
Application granted granted Critical
Publication of FR3099701B1 publication Critical patent/FR3099701B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L’invention a pour objet l’utilisation cosmétique d’une combinaison d’oenothéine-B et de quercétine-3-o-glucuronide pour prévenir une augmentation et/ou diminuer la production de sébum au niveau de la peau. La combinaison permet de prévenir une augmentation et/ou diminuer la visibilité des pores de la peau. Un autre objet concerne un procédé de soin cosmétique comprenant l’administration par voie topique ou orale d’une composition comprenant une combinaison d’oenothéine-B et de quercétine-3-O-glucuronide pour prévenir une augmentation et/ou diminuer la production de sébum au niveau de la peau et/ou prévenir une augmentation et/ou diminuer la visibilité des pores de la peau. Un autre objet est relatif à la combinaison d’oenothéine-B et de quercétine-3-o-glucuronide pour son utilisation pour le traitement des pathologies séborrhéiques, préférentiellement les hyperséborrhées pathologiques, l’eczéma séborrhéique et/ou l’hypersécrétion du nourrisson et/ou l'une quelconque de leurs combinaisons.The subject of the invention is the cosmetic use of a combination of oenotheine-B and quercetin-3-o-glucuronide to prevent an increase and/or decrease in the production of sebum in the skin. The combination makes it possible to prevent an increase and/or decrease in the visibility of the pores of the skin. Another subject relates to a cosmetic care process comprising the topical or oral administration of a composition comprising a combination of oenothein-B and quercetin-3-O-glucuronide to prevent an increase and/or decrease the production of sebum in the skin and/or preventing an increase and/or decreasing the visibility of the pores of the skin. Another object relates to the combination of oenotheine-B and quercetin-3-o-glucuronide for its use for the treatment of seborrhoeic pathologies, preferentially pathological hyperseborrhoea, seborrheic eczema and/or hypersecretion in infants and /or any combination thereof.

FR1909080A 2019-08-08 2019-08-08 New cosmetic use of a combination of oenotheine-B and quercetin-3-O-glucuronide Active FR3099701B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1909080A FR3099701B1 (en) 2019-08-08 2019-08-08 New cosmetic use of a combination of oenotheine-B and quercetin-3-O-glucuronide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1909080A FR3099701B1 (en) 2019-08-08 2019-08-08 New cosmetic use of a combination of oenotheine-B and quercetin-3-O-glucuronide
FR1909080 2019-08-08

Publications (2)

Publication Number Publication Date
FR3099701A1 FR3099701A1 (en) 2021-02-12
FR3099701B1 true FR3099701B1 (en) 2022-03-25

Family

ID=68807061

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1909080A Active FR3099701B1 (en) 2019-08-08 2019-08-08 New cosmetic use of a combination of oenotheine-B and quercetin-3-O-glucuronide

Country Status (1)

Country Link
FR (1) FR3099701B1 (en)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR654316A (en) 1927-06-30 1929-04-04 Ig Farbenindustrie Ag Process for the production of hydrocarbon derivatives and unsaturated hydrocarbons
FR2712495B1 (en) * 1993-11-16 1996-01-05 Roussel Uclaf Application of Óoenotheine B to obtain a medicament intended for the treatment of disorders linked to hyperandrogenism, and the pharmaceutical compositions containing it.
FR2712594B1 (en) 1993-11-16 1996-12-27 Roussel Uclaf Process for the preparation of oenotheine B from Epilobium Parviflorum.
FR2784029B1 (en) 1998-10-05 2001-01-05 Pharmascience Lab METHOD FOR THE PREVENTION AND / OR COSMETIC TREATMENT OF STRETCH MARKS AND USE IN DERMATOLOGY
CA2386648A1 (en) 2002-05-16 2003-11-16 Fytokem Products Inc. Compositions and methods for managing bacterial skin conditions
FR2855968B1 (en) 2003-06-13 2012-11-30 Coletica STIMULATION OF THE SYNTHESIS AND ACTIVITY OF A LYSYL OXIDASE-LIKE LOXL ISOFORM TO STIMULATE THE FORMATION OF ELASTIC FIBERS
FR2893252B1 (en) 2005-11-17 2008-02-15 Engelhard Lyon Sa VEGETABLE EXTRACTS STIMULATING HAS2
GB0912481D0 (en) * 2009-07-17 2009-08-26 Reckitt Benckiser Healthcare I Skincare compositions
US20110034427A1 (en) 2009-08-06 2011-02-10 Eustathios Gonos Anti-aging properties of quercetin, 18alpha-glycyrrhetinic acid and hederagenin and their derivatives
FR2994387B1 (en) 2012-08-13 2016-07-29 Basf Beauty Care Solutions France Sas COSMETIC OR PHARMACEUTICAL MOISTURIZING INGREDIENT
MY172154A (en) 2012-08-29 2019-11-14 Biotropics Malaysia Berhad Composition for cognition and cosmetic purposes and use of said composition for preparing an agent
KR102230576B1 (en) 2013-08-22 2021-03-23 루카스 마이어 코스메틱스 캐나다 인크. Methods of use of anti-dandruff compositions
FR3034664B1 (en) 2015-04-09 2018-09-14 ISP Investments LLC. HYDRO-ALCOHOLIC EXTRACT OF SCHINUS MOLLE, COSMETIC COMPOSITIONS COMPRISING SAME AND THEIR COSMETIC USES
CN106727044A (en) * 2017-02-11 2017-05-31 佛山文森特知识产权服务有限公司 A kind of bamboo charcoal oil control and acne removal facial mask

Also Published As

Publication number Publication date
FR3099701A1 (en) 2021-02-12

Similar Documents

Publication Publication Date Title
EP4297868A4 (en) USE OF APREPITANT FOR THE TREATMENT OF ALZHEIMER'S DISEASE
EP3737361A4 (en) DIHYDROCERAMIDE DESATURASE INHIBITORS FOR THE TREATMENT OF DISEASE
MA49131A (en) USE OF KLK5 ANTAGONISTS FOR THE TREATMENT OF DISEASE
MA44935A1 (en) Pharmaceutical compositions containing an alpha 4 integrin antagonist, used for the treatment of inflammatory conditions of the eye
FR3014682B1 (en) CAPILLARY COLORING PROCESS IMPLEMENTING AT LEAST ONE ORTHODIPHENOL, A TITANIUM DERIVATIVE, AND A CARBOXYLIC ACID
FR3064476B1 (en) COSMETIC TREATMENT PROCESS FOR KERATINIC FIBERS INCLUDING THE APPLICATION OF A BASE COMPOSITION AND OF A COMPOSITION INCLUDING A CATIONIC SURFACTANT
MA53739A (en) COMPOSITION AND USE FOR THE TREATMENT OF PARKINSON'S DISEASE AND RELATED DISORDERS
FR3064477B1 (en) COSMETIC TREATMENT PROCESS FOR KERATINIC FIBERS INCLUDING THE APPLICATION OF A BASE COMPOSITION AND OF A COMPOSITION INCLUDING AN AMINOUS SILICONE
IL309468A (en) Biomarkers for the treatment of Alzheimer's disease
FR3069159B1 (en) HAIR TREATMENT AGENT
FR3046069B1 (en) COMPOSITION FOR CLEANING THE SKIN
FR3099701B1 (en) New cosmetic use of a combination of oenotheine-B and quercetin-3-O-glucuronide
FR3078253B1 (en) Conditioning agent to improve hair shine
EP3451897A4 (en) METHODS OF OBTAINING RETINAL 3D BLOOD VESSEL GEOMETRY FROM OPTICAL COHERENCE TOMOGRAPHY IMAGES, AND METHODS OF ANALYSIS THEREOF
EP3802568A4 (en) PEPTIDE THERAPEUTIC AGENTS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED CONDITIONS
EP4010367A4 (en) USE OF ASS34 TO ASSESS THE PROGRESSION OF ALZHEIMER’S DISEASE
EA201991185A1 (en) COMPOSITIONS FOR PERSONAL HYGIENE CONTAINING CYSTINE
FR3092998B1 (en) Cosmetic composition based on plant products
FR3089816B1 (en) Cleansing hair oil, method of application and use for caring for keratin fibers
EP3646872A4 (en) AGENT FOR THE PREVENTION AND / OR TREATMENT OF ALZHEIMER'S DISEASE
FR3061013B1 (en) COMPOSITION CONTAINING DIGENEASIDE, PROCESS FOR OBTAINING SAME AND ITS COSMETIC, VETERINARY OR NUTRACEUTICAL USE
FR3090376B1 (en) Aqueous extract of Rose fruits as a cutaneous neuro-protective agent
FR3031301B1 (en) NOVEL COMPOSITION COMPRISING CHROMIUM AND TYROSINE DERIVATIVES FOR THE TREATMENT OF SKIN
Balaji Volunteerism in COVID-19 pandemic
FR3047990B1 (en) SKIN COSMETIC COMPOSITION INCLUDING A PEPTIDE SDKP OR ANALOGUE OF THE SAME

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20210212

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7